Plain-English translation of NCT07445074 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a mobile app called Medilepsy® that uses artificial intelligence to help young people with epilepsy remember and stick with their seizure medications. Some participants will use a version of the app with AI features that learns from how you use it and gives personalized reminders, while others will use a standard version without AI. The study wants to see if the AI-powered version works better at helping you take your medicines on time and prepare for the transition to adult healthcare.
Many young people with epilepsy struggle to take their medications consistently, which can lead to more seizures and health complications. This trial is designed to find out whether an AI-powered app can make it easier and more natural for teenagers and young adults — especially those from communities that don't always have easy access to healthcare — to stay on top of their medication routine.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to use either the AI-powered version or the standard version of the Medilepsy® app on your own mobile device. Throughout the study, you'll use the app to help track and manage your seizure medications, and the app will send you reminders and support. Researchers will check in with you periodically to see how well the app is working, how easy it is to use, and whether it's helping you remember your medicines and prepare for managing your epilepsy as you get older.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States